- Home
- AMSF vs PACB Comparison
AMSF vs PACB Comparison
Compare AMSF & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMSF | PACB |
|---|---|---|
| Founded | 1985 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Accident &Health Insurance | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 630.9M | 459.0M |
| IPO Year | 1996 | 2010 |
Fundamental Metrics
Financial Performance| Metric | AMSF | PACB |
|---|---|---|
| Price | $32.85 | $1.33 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $50.33 | $2.10 |
| AVG Volume (30 Days) | 153.5K | ★ 5.8M |
| Earning Date | 05-28-2026 | 01-01-0001 |
| Dividend Yield | ★ 8.02% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.47 | N/A |
| Revenue | ★ $317,252,000.00 | $93,468,000.00 |
| Revenue This Year | $8.06 | $11.22 |
| Revenue Next Year | $6.34 | $12.41 |
| P/E Ratio | $13.33 | ★ N/A |
| Revenue Growth | 2.66 | ★ 3.04 |
| 52 Week Low | $32.00 | $0.85 |
| 52 Week High | $53.27 | $2.73 |
Technical Indicators
Market Signals| Indicator | AMSF | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 33.19 | 34.01 |
| Support Level | $32.00 | $1.18 |
| Resistance Level | $39.59 | $1.37 |
| Average True Range (ATR) | 1.19 | 0.10 |
| MACD | -0.20 | -0.01 |
| Stochastic Oscillator | 14.18 | 14.55 |
Price Performance
Historical ComparisonAbout AMSF AMERISAFE Inc.
AMERISAFE Inc is a specialty provider of workers' compensation insurance focused on small to mid-sized employers engaged in hazardous industries, principally construction, trucking, logging and lumber, agriculture, manufacturing, maritime, and telecommunications. The company generates a majority of its revenue in the form of premiums. The Company operates as a single reportable segment, Insurance Operations.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.